Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer
Elastin-like polypeptides (ELP) are versatile protein biopolymers used in drug delivery due to their modular nature, allowing fusion of therapeutics and targeting agents. We previously developed an ELP fusion with vascular endothelial growth factor (VEGF) and demonstrated its therapeutic efficacy in...
Main Authors: | Fakhri Mahdi, Alejandro R. Chade, Gene L. Bidwell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/10/542 |
Similar Items
-
A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia
by: Omar C. Logue, et al.
Published: (2017-12-01) -
Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery
by: Sonja Dragojevic, et al.
Published: (2022-02-01) -
Facile Synthesis of Peptide-Conjugated Gold Nanoclusters with Different Lengths
by: Qun Ma, et al.
Published: (2021-11-01) -
Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study
by: Jung Su Ryu, et al.
Published: (2021-01-01) -
Biosynthesized Multivalent Lacritin Peptides Stimulate Exosome Production in Human Corneal Epithelium
by: Changrim Lee, et al.
Published: (2020-08-01)